Should Evidence-Based Proof of Efficacy as Defined for a Specific Therapeutic Agent Be Extrapolated to Encompass a Therapeutic Class of Agents?

Circulation - United States
doi 10.1161/01.cir.0000090571.83005.ce
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search